Search This Blog

Tuesday, November 12, 2019

Catalyst Pharmaceuticals EPS beats by $0.02, misses on revenue

Catalyst Pharmaceuticals (NASDAQ:CPRX): Q3 GAAP EPS of $0.13 beats by $0.02.
Revenue of $30.9M misses by $2.29M.
Shares -8.4%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)